ABVC BioPharma rises after CEO appointment
26/06/2023 16:39
** Shares of drug developer ABVC BioPharma Inc ABVC.O rise
7.7% to $0.57
** Co announces appointment of Dr. Uttam Yashwant Patil as
the new chief executive officer, effective June 23
** Patil has previously been chief operating officer & chief
scientific officer of BioKey Inc, a facility owned by ABVC
** Stock down ~7% YTD
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner